/

DIM.PA

SARTORIUS STED BIOClosed

213.60+0.80 +0.38%EUR

Paris · as of Oct 13, 11:35 ET · 15m delay

Open

216.20

Prev close

212.80

Day range

212.60216.60

52-week range

150.00225.00

Volume

76.90K0.85×

Mkt cap

20.78B

P/E ttm

70.96

Fwd P/E

35.50

EPS ttm

3.01

Div yield

0.32%

Earnings

Oct 22, 2026

From 52w high

−5.07%

Price Chart

Yahoo Finance · delayed

DIM.PAOct 13, 2026O 216.20H 216.60L 212.60C 213.60+0.80 (+0.38%)Vol 76.90K

SMA 50196.31
SMA 200182.29

1Y change +13.86% since Oct 10, 2025 close550 bars loadedTimes in Europe/ParisDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

DIM.PA SARTORIUS STED BIO · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: −1.02%
1 month: +14.29%
3 months: +13.32%
6 months: +18.14%
Year to date: +1.71%
1 year: +14.16%

Valuation & ownership

Market cap: 20.78B
Enterprise value: 22.82B
P/E (ttm): 70.96
Forward P/E: 35.50
PEG ratio: 1.53
Price / book: 4.88
Price / sales (ttm): 6.92
EV / EBITDA: 27.96
EPS (ttm): 3.01
EPS (forward): 6.02
Beta (5y monthly): 1.10
Dividend yield: 0.32%
Payout ratio: 22.92%
Shares outstanding: 97.29M
Float: 27.62M
Short % of float: —
Short ratio (days): —
Held by insiders: 71.50%
Held by institutions: 11.76%
Avg volume (3m): 90.59K
50-day average: 194.68
200-day average: 181.84
52-week change: +14.16%
S&P 500 52-week: +17.50%

Technicals (daily)

RSI (14): 58.5
vs 50-day SMA: +8.81%
vs 200-day SMA: +17.18%
50 / 200-day trend: ▲ 50 above 200
MACD vs signal: ▼ below
ATR (14) % of price: 3.15%
Realised vol (20d, ann.): 35.4%
From 52-week high: −5.07%
From 52-week low: +42.40%

ANR

Analyst Consensus

14 analysts

Consensus

Strong buy

1.50 on a 1 (strong buy) – 5 (sell) scale

Mean target

237.29

+11.09% implied

Low 210.00Median 239.50High 262.00

Recommendation trend

Now13 / 1 / 0
1m ago / 1 /

DES

About SARTORIUS STED BIO

Yahoo Finance profile

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides fluid management services; biolayer interferometry instruments; microbiology testing, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; screening instruments; biomolecule analysis tools; batch liquid chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; water purification systems; and weighing products. In addition, the company offers data analytics software; process automation platform and software; and transfection reagents and plasmid DNA solutions. The company has a collaboration with Bio Usawa Biotechnology, Ltd. focusing on developing and manufacturing monoclonal antibodies in Sub-Saharan Africa to tackle oncology, diabetes-induced eye diseases, infectious diseases, and autoimmune conditions. It serves manufacturers of medications, vaccines, food, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.

Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 10,477
Headquarters: Aubagne, France
Website: sartorius.com
Officers

SEAS

Seasonality · DIM.PA

2007–2026 · monthly returns

Strongest month Jul +5.99%Weakest month Sep −2.79%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	-10.3	-2.8	-9.2	-5.7	13.7	2.0	-8.2	17.6	8.6	0.4			+1.7%
2025	18.4	-10.9	-8.4	13.1	-5.9	4.5	-13.2	-0.6	-1.6	20.4	0.0	1.3	+11.3%
2024	4.9	1.2	3.9	-23.2	-10.0	-16.1	20.6	-0.5	2.0	-2.4	-1.6	4.6	−21.2%
2023	5.4	-3.2	-8.6	-14.0	1.3	-6.9	24.4	-7.9	-13.8	-21.9	16.9	16.0	−20.8%
2022	-19.8	-11.3	8.5	-16.0	2.6	-6.8	30.2	-6.1	-13.3	1.3	0.7	-6.4	−37.3%
2021	18.5	4.9	-3.0	8.8	-7.2	12.6	20.7	6.7	-5.8	-1.6	9.5	-7.5	+65.7%
2020	9.7	5.9	6.6	19.7	11.3	-7.7	17.3	13.6	-1.7	10.5	-6.9	-3.9	+97.2%
2019	10.2	7.5	9.1	7.2	2.6	11.8	4.3	-2.7	-8.8	4.5	7.4	2.5	+69.1%
2018	15.8	4.3	0.9	5.4	9.6	5.5	13.7	7.3	8.5	-7.5	-18.4	-2.3	+44.9%
2017	-6.6	7.4	5.0	-2.5	13.8	-3.1	-11.3	2.2	-4.8	-0.2	2.7	0.3	+0.5%
2016	-4.8	12.5	-11.6	-0.3	6.2	3.3	4.1	-0.7	6.1	-8.1	-2.1	-0.3	+1.8%
2015	7.0	13.9	0.6	14.9	5.9	2.9	14.8	0.6	-6.9	20.8	6.2	3.5	+119.1%
2014	8.6	13.0	-2.6	-5.9	-3.3	-1.0	-1.6	-3.8	6.6	10.0	3.1	7.5	+32.4%
2013	22.2	13.5	2.2	3.5	-7.9	1.4	12.9	5.2	-6.2	-1.1	4.4	5.4	+66.0%
2012	5.2	4.2	-1.9	1.0	7.3	1.2	16.4	2.5	1.4	-0.4	7.6	-2.1	+49.8%
2011	3.9	6.1	-0.7	2.4	7.5	5.0	5.0	-1.1	-8.5	8.2	-11.1	12.5	+30.0%
2010	8.9	18.1	5.3	-3.1	-3.3	-4.1	-4.9	0.2	6.1	-4.2	-3.0	17.8	+34.6%
2009	16.5	9.6	9.6	20.9	9.3	18.5	-9.7	7.6	1.1	5.2	-1.7	-3.3	+115.4%
2008	-21.4	-6.9	3.7	18.1	-12.3	-5.5	-20.6	27.4	-2.5	-17.6	-26.3	-20.7	−64.8%
2007	2.1	19.1	1.3	-2.9	4.9	0.6	-9.3	-5.1	-10.8	-3.9	-10.6	11.6	−7.2%

DIM.PA

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

DIM.PA

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About SARTORIUS STED BIO

Seasonality · DIM.PA

Insider Activity · DIM.PA

Congress Trades · DIM.PA

Investors Holding DIM.PA

Investors Holding DIM.PA

Congress Trades · DIM.PA

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About SARTORIUS STED BIO

Financial Snapshot

Earnings & Dividends

News

Insider Activity · DIM.PA

Seasonality · DIM.PA